This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Novartis AG

Drug Names(s): Signifor LAR, SOM230 long-acting release (LAR), Pasireotide, somatostatin analog

Description: SOM230 is a novel, stable cyclohexapeptide somatostatin analogue which exhibits unique binding to human somatostatin receptors (sst1-5). SOM230 inhibits growth hormone and insulin-like growth factor 1.

Signifor News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug